Disseminated malignant neoplasm, unspecified
ICD-10 C80.0 is a billable code used to indicate a diagnosis of disseminated malignant neoplasm, unspecified.
C80.0 refers to disseminated malignant neoplasm, which indicates the presence of cancer that has spread throughout the body without a known primary site. This code is often used when the cancer has metastasized to multiple organs or systems, and the origin of the malignancy cannot be determined. Patients with this diagnosis may present with various symptoms depending on the organs affected, including weight loss, fatigue, pain, and organ dysfunction. The staging of disseminated malignant neoplasm is typically classified as stage IV, indicating advanced disease. Treatment often focuses on palliative care, aiming to relieve symptoms and improve quality of life rather than cure the disease. This may involve chemotherapy, radiation therapy, or supportive care measures. Accurate coding is crucial for appropriate treatment planning and reimbursement, as well as for tracking cancer epidemiology and outcomes.
Detailed history of cancer diagnosis, treatment history, and current symptoms.
Patients presenting with symptoms of advanced cancer without a known primary site.
Ensure all metastatic sites are documented and correlate with imaging studies.
Comprehensive assessment of patient symptoms and quality of life considerations.
Patients requiring symptom management for advanced cancer.
Focus on patient-centered care and documentation of goals of care discussions.
Used for follow-up visits for patients with disseminated malignancy.
Document history, examination findings, and medical decision-making.
Oncology specialists should include treatment plans and symptom management strategies.
C80.0 should be used when a patient has a malignant neoplasm that has spread throughout the body, and the primary site cannot be determined despite thorough investigation.
